CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY MARKET BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDING OF THE STUDY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW
3.3. MARKET SIZE AND FORECAST
3.3.1. Number of infertility clinics, 2015
3.4. REGULATORY ISSUES, LEGISLATIONS, AND AUTHORITIES
3.5. INSURANCE REIMBURSEMENT SCENARIO
3.6. KEY IMPACTING FACTORS
3.6.1. Drivers
3.6.1.1. Increasing popularity of IVF in the U.S.
3.6.1.2. Increased rate of infertility and practices of embryo banking cycles
3.6.1.3. Delayed pregnancy
3.6.1.4. Technological advancements in IVF treatment
3.6.2. Restraints
3.6.2.1. High cost of IVF treatments in the U.S.
3.6.2.2. Restrictions on three-parent IVF treatments
3.6.2.3. Scattered Reimbursements
CHAPTER 4 U.S. IVF SERVICES MARKET, BY END USER
4.1. OVERVIEW
4.2. MARKET SIZE AND FORECAST
4.3. FERTILITY CLINICS
4.4. HOSPITALS
4.5. SURGICAL CENTERS
4.6. CLINICAL RESEARCH INSTITUTES
CHAPTER 5 U.S. IVF SERVICES MARKET, BY CYCLE TYPE
5.1. OVERVIEW
5.2. MARKET SIZE AND FORECAST
5.3. FRESH IVF CYCLES (NON-DONOR)
5.4. THAWED IVF CYCLES (NON-DONOR)
5.5. DONOR EGG IVF CYCLES
CHAPTER 6 COMPANY/HOSPITALS/CLINICS PROFILES
6.1. FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.1.1. Overview
6.2. CONCEPTIONS REPRODUCTIVE ASSOCIATES
6.2.1. Overview
6.3 SERVY MASSEY FERTILITY INSTITUTE
6.2.2. Overview
6.4 SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
6.2.3. Overview
6.5 CARDONE REPRODUCTIVE MEDICINE & INFERTILITY
6.2.4. Overview
6.6 FERTILITY CENTER OF SAN ANTONIO
6.2.5. Overview
6.7. HOUSTON FERTILITY CENTER
6.7.1. Overview
6.8. NEW HOPE FERTILITY CENTER
6.8.1. Overview
6.9. REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
6.9.1. Overview